Where is the live CopyMark page for USPTO serial 79020247?

The live record is at https://getcopymark.com/trademark/79020247. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns Serial No. 79020247?

According to the public USPTO record for serial number 79020247, the listed owner(s) include: DeveloGen Aktiengesellschaft für; entwicklungsbiologische Forschung, DeveloGen Aktiengesellschaft für; entwicklungsbiologische Forschung, DeveloGen Aktiengesellschaft für; entwicklungsbiologische Forschung.

What is USPTO serial number 79020247?

Serial number 79020247 is the USPTO application identifier for the mark Serial No. 79020247. It is used to track examination, publication, and registration of this trademark.

What is the current status of Serial No. 79020247?

Serial No. 79020247 (79020247) currently shows USPTO status code 404 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover Serial No. 79020247?

The public record lists International Classes: 005, 042. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: Serial No. 79020247 Serial# 79020247 | status 404; last event DENC | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 79020247?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Goods and services

Class	Description	Status	First use
005	Pharmaceutical and veterinary preparations, namely, substances for the treatment of metabolic syndrome, obesity, diabetes, cardiovascular, central nervous system and related disorders and diseases; vaccines; diagnostics and reagents for medical and pharmaceutical purposes	SECTION 71 - CANCELLED	—
042	Scientific and industrial research, namely in the medical and pharmaceutical field; Medical and scientific research, namely conducting clinical trials; Rendering technical opinions in the medical and pharmaceutical field; Medical and pharmaceutical consultancy and research services rendered by biologists, biochemists and chemists; Computer software design and computer programming; Development, updating and maintenance of databases; Providing a website that features information and data on medical and pharmaceutical research and related clinical studies; Consulting and legal services in the field of the application procedure for governmental drug approval	SECTION 71 - CANCELLED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Jan 24, 2014	DENC	NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED	—
Jan 24, 2014	DETH	DEATH OF INTERNATIONAL REGISTRATION	—
Dec 27, 2013	C71T	CANCELLED SECTION 71	—
Aug 14, 2008	FINO	FINAL DECISION TRANSACTION PROCESSED BY IB	—
Oct 30, 2007	FICS	FINAL DISPOSITION NOTICE SENT TO IB	—
Oct 30, 2007	FIMP	FINAL DISPOSITION PROCESSED	—
Oct 15, 2007	FICR	FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB	—
May 22, 2007	R.PR	REGISTERED-PRINCIPAL REGISTER	Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 6, 2007	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 14, 2007	NPUB	NOTICE OF PUBLICATION	—
Jan 12, 2007	PREV	LAW OFFICE PUBLICATION REVIEW COMPLETED	—
Jan 12, 2007	ALIE	ASSIGNED TO LIE	—
Dec 16, 2006	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Nov 16, 2006	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Nov 16, 2006	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Nov 16, 2006	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 8, 2006	RFNT	REFUSAL PROCESSED BY IB	—
May 23, 2006	RFCS	NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	—
May 23, 2006	RFRR	REFUSAL PROCESSED BY MPU	—
May 20, 2006	RFCR	NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	—
May 19, 2006	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 19, 2006	DOCK	ASSIGNED TO EXAMINER	—
Feb 24, 2006	NWAP	NEW APPLICATION ENTERED	—
Feb 24, 2006	SDRC	SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB	—

Serial No. 79020247